
    
      Three-way bridge phase 1 trial. It is conducted in healthy, male adult subjects, it is
      single-dose, double-blind, parallel groups, randomized and balanced.

      Blood samples are collected up to 90 days, to dermine serum drug concentration and anti-drug
      antibodies. Safety and tolerabilty is also evaluated.
    
  